Articles
Oligonucleotide Manufacturers are Actively Investing and Collaborating to Expanding
by Roots Analysis Roots Analysis provides market research and consulIn
the pharmaceutical industry, stakeholders are known to adopt a variety
partnerships and expansion models. Such initiatives not only allow the
companies to expand their respective product / service portfolio, but also to gain
additional capabilities in emerging technologies. Owing to the
complexities associated with synthesis of oligonucleotides and requirement of
complex analytical expertise, several service providers have made significant
investments to expand their respective production capabilities and capacities.
Certain players have also established new manufacturing facilities in order to
cater to the growing demand for these molecules.
During our research, we came across 32 expansions, reported in
the public domain during the period 2014-2019. Majority
(15) of the expansion initiatives within this domain were observed to be
carried out for strengthening the manufacturing related operations. Further, over 60% of
the instances were focused on expanding all the scales of operations.
In North America, 50% of the instances were of capability
expansion, while 25% were aimed at establishment of new manufacturing
facilities. A similar trend was observed in Europe, where 50% of the expansions
were focused on capability expansion of existing facilities and 38% were aimed
at establishment of new facilities.
The field has also witnessed the establishment of multiple
partnerships between drug developers or equipment suppliers and contract
service providers, in the past few years. During our research, we came across
close to 35 partnership agreements, inked during the period 2014-2019. It is
worth highlighting that the maximum number of partnerships (10) were recorded
in 2016; of these, eight agreements were signed in the second half of the year.
It is worth mentioning that, majority (21%) of the instances
were reported to be manufacturing and supply agreements, followed by mergers /
acquisitions (20%). Most of the agreements (69%) within this domain were
signed between industry players located in the same region. Furthermore, in
most of the intercontinental agreements, the leading partner (company providing
services related to oligonucleotides) was observed to be based in North America.
Complete report by Roots Analysis: Oligonucleotide
Synthesis, Modification and Purification Services Market: Focus on Research,
Diagnostic and Therapeutic Applications, 2020-2030
Sponsor Ads
About Roots Analysis 
Roots Analysis provides market research and consul
13 connections, 0 recommendations, 44 honor points.Joined APSense since, June 3rd, 2020, From Chandigarh, India.
Created on Jun 18th 2020 01:43. Viewed 196 times.
